P132 (Trial in Progress) A phase 2, open-label, randomized multicenter trial to evaluate neoadjuvant lasofoxifene in molecularly-selected HR+/HER2− Clinical Stage 2/3 breast cancer

• J. Chien,
• L. Esserman,
• A. Elias,
• M. Wei,
• P. Plourde,
• D. Portman

Affiliations

J. Chien

L. Esserman

A. Elias

M. Wei

P. Plourde

D. Portman